Shady Soliman
Papers
1
Total Citations
29
H-Index
1
About
Dr. Shady Soliman is a leading urologic oncologist whose research centers on optimizing surgical outcomes for upper tract urothelial carcinoma (UTUC), with a particular focus on the role of robotic surgery and lymph node dissection. His most cited work, a landmark 2022 analysis of the multi-institutional ROBUUST registry, rigorously evaluated the impact of lymph node dissection during nephroureterectomy. This study, which has garnered 29 citations, provided critical, evidence-based insights into patient selection and the potential survival benefits of the procedure, helping to refine surgical guidelines for this rare but aggressive cancer. Dr. Soliman’s contributions are foundational to the growing field of robotic UTUC surgery, and his leadership within the ROBUUST consortium has established a vital data infrastructure for future research. By translating complex surgical data into actionable clinical knowledge, his work directly informs the decision-making of urologists worldwide, ultimately aiming to improve long-term outcomes for patients battling this challenging disease.
Research Focus
Key Achievements
Top Papers
- 1